A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer

This study has been terminated.

( Study stopped to avoid treating enrolled subjects to hemoglobin levels higher than those specified in current labeling. )

Study NCT00246597 Information provided by Ortho Biotech Products, L.P.

First Received: October 28, 2005 Last Updated: May 17, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	June 2004
Estimated Primary Completion Date:	No date given